Current Opinion in Biotechnology

Papers
(The H4-Index of Current Opinion in Biotechnology is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Editorial Board259
Editorial Board201
Corrigendum to “Methylotrophs: from C1 compounds to food” [Curr Opin Biotechnol 75 (2022) 102685]120
Stem cells characterization: OMICS reinforcing analytics120
Systems biology-based analysis of cell-free systems110
How much could improving photosynthesis increase crop yields? A call for systems-level perspectives to guide engineering strategies108
Anaerobic microbial methanol utilization as a one-carbon feedstock102
Recent progress in the synthesis of advanced biofuel and bioproducts97
Tumor lipid metabolism: a mechanistic link between diet and cancer progression97
Bioelectrosynthesis systems93
The osteo-angiogenic signaling crosstalk for bone regeneration: harmony out of complexity90
Synthetic biology advances towards a bio-based society in the era of artificial intelligence90
Cell-free technologies for biopharmaceutical research and production87
The journey of a lifetime — development of Pfizer’s COVID-19 vaccine86
Applications of artificial intelligence to enzyme and pathway design for metabolic engineering83
Creating value from purple phototrophic bacteria via single-cell protein production78
Editorial Board66
A molecular assessment of the practical potential of DNA-based computation65
Recent advances, opportunities and challenges in cybergenetic identification and control of biomolecular networks65
Genetically encoded elastin-like polypeptide nanoparticles for drug delivery63
Engineered T cells and macrophages: two arms to seize solid tumors63
The plant microbiota: composition, functions, and engineering60
Bridging the gap — biomimetic design of bioelectronic interfaces58
Coupling chemistry and biology for the synthesis of advanced bioproducts55
Lighting the way: recent developments and applications in molecular optogenetics54
Deep learning in regulatory genomics: from identification to design53
Leveraging rAAV bioprocess understanding and next generation bioanalytics development52
Whole-plant phenotypic engineering: moving beyond ratios for multi-objective optimization of nutrient use efficiency51
Innovations and trends in antibody repertoire analysis51
Emerging technologies for genetic control systems in cellular therapies51
Engineered living bioassemblies for biomedical and functional material applications50
2-hydroxyglutarate rides the cancer-immunity cycle50
Single-cell analysis opens a goldmine for plant functional studies50
Emerging trends in production of plant natural products and new-to-nature biopharmaceuticals in yeast50
Engineering of the genetic code48
Biocatalytic cascade transformations for the synthesis of C-nucleosides and N-nucleoside analogs47
Dietary microalgae on poultry meat and eggs: explained versus unexplained effects47
Computational tools and resources for designing new pathways to small molecules47
Using genome and transcriptome analysis to elucidate biosynthetic pathways46
Mass spectrometry imaging methods for visualizing tumor heterogeneity45
Multifaceted metabolic role of infections in the tumor microenvironment45
Machine learning to navigate fitness landscapes for protein engineering44
Perspectives for self-driving labs in synthetic biology44
0.55029106140137